Fundraising Fox

Eef Schimmelpennink

Executive at Lenz

San Diego, California, United States

Find your path to Eef

379 people in our graph share verified history with Eef — schools, employers, funds. One of them is your warm intro.

Tony ConradunlockedEef: together at Numico (1997)
×3Eef: together at Queensland University of Technology
×3Eef: together at Numico
×4Eef: together at Pfizer

About

Eef Schimmelpennink serves as President and CEO of LENZ Therapeutics, a biopharmaceutical company listed on NASDAQ under the ticker LENZ. Schimmelpennink has more than 20 years of experience across areas including R&D, commercial operations, public and private finance, business development, and manufacturing.

Executive at Lenz

Intro paths

→

In turn, Eef can intro founders to Lenz's investors below.

Lenz's investors · 6

Alpha Wave GlobalMiamiRA CapitalBoston · since 2023Raptor GroupMiami BeachRTW Investments L.P.New York · since 2023Sectoral Asset ManagementMontreal · since 2023Versant VenturesSan Francisco · $250K – $5M checks · since 2023

Co-founders at Lenz

JMJames McCollum
James McCollumCo-founder, Board Member

Experience

  1. LENZ TherapeuticsPresident and CEOcurrent2021 — presentSan Diego, California, United States
  2. iBio, Inc.Member Board Of Directorscurrent2021 — present
  3. Pipeline TherapeuticsChair of the Board of Directorscurrent2022 — presentSan Diego, California, United States
  4. Pfenex Inc. (PFNX : NYSE)CEO and President2017 — 2020San Diego
  5. AlvotechCEO2015 — 2017Reykjavik, Iceland
  6. PfizerVice President - Global Sterile Injectables2015New York / Lake Forest Chicago Area
  7. HospiraVice President - Global Generics2012 — 2015Lake Forest, Chicago, IL, USA
  8. HospiraDirector of Specialty Injectable Pharma Marketing EMEA & Director of Distributor Operations EMEA2011 — 2012United Kingdom
  9. Synthon BVVice President Marketing and Sales2008 — 2011Netherlands
  10. Synthon BVDirector Business Development2007Netherlands
  11. Synthon BVBusiness Development Manager2006Netherlands
  12. Synthon BVSenior International Product Manager2005 — 2006Netherlands
  13. Synthon BVInternational Product Manager2002 — 2004Netherlands
  14. NumicoInternational Product Manager2000 — 2002Netherlands
  15. NumicoResearcher Product Development1997 — 2000Netherlands

Skills & more

Strategy33Biopharmaceuticals14Biosimilars15Biotechnology34Business Development68Cardiology4Clinical Development4Commercialization8Clinical Trials3Cross-functional Team Leadership19Drug Development4FDA5
+10 moreGMPGeneric ProgrammingHospital SalesLife SciencesLifesciencesMarket AccessMarket AnalysisNew Business DevelopmentOncologyR

From Eef's professional profile.

Frequently asked questions

Who is Eef Schimmelpennink?
Eef Schimmelpennink serves as President and CEO of LENZ Therapeutics, a biopharmaceutical company listed on NASDAQ under the ticker LENZ. Schimmelpennink has more than 20 years of experience across areas including R&D, commercial operations, public and private finance, business development, and manufacturing.
Where did Eef Schimmelpennink go to school?
Eef Schimmelpennink studied at Wageningen University & Research (MSc, Bioprocess Engineering); QUT (Queensland University of Technology) (Bioprocess Engineering); Business School Arnhem (Business).

Same school

Also attended Wageningen University & Research51

Xavier MesnierPartner, Head of Frontiers in Health & Bio Investments at Verve VenturesThomas van den BoezemPartner at PeakBridge VCLaura ArgelichAssociate at Ysios CapitalPavlos KalaitzoglouDirector of Research at Astanor VenturesMichel BriejerManaging Partner at Thuja CapitalMarcel ZijpSenior Investment Manager at Brightlands Venture Partners

+ 45 more

Also attended QUT (Queensland University of Technology)111

Esther GilmoreGlobal Head of the Client Team at Generation Investment ManagementDon MeijEntrepreneur in Residence at StripesSam EdenInvestor at Square Peg CapitalAndrew PoesastePartner at RampersandFredrik BergenlidPartner at Fly VenturesReuben BramaInvestor at IDEO CoLab Ventures

+ 105 more

Shared employers

Also worked at iBio, Inc.6

Elizabeth StonerEntrepreneur Partner at MPM BioImpactDoug HicksEntrepreneur-In-Residence at The Innovation SpaceFelipe DuranExecutive Officer at iBioMarc BanjakExecutive Officer at iBioMartin A. BrennerExecutive Officer, Director at iBioTerence RyanChief Scientific Officer at iBio

Also worked at Pipeline Therapeutics4

Asish K. XavierVice President, Venture Investments at JJDCFrançois BeaubienPartner at Sectoral Asset ManagementTroy IgnelziExecutive Officer at Juventas TherapeuticsDaniel S. LorrainChief Scientific Officer at Contineum Therapeutics

Also worked at Pfizer401

Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital

+ 395 more

Also worked at Hospira13

Stephanie MorrisPrincipal at ArtesianGeoff ThomasSenior Investment Manager at PaspalisRohit RazdanManaging Director at Tenacity VenturesEric FloydRegulatory Advisor at 2Flo VenturesMary GardnerChief Executive Officer & Founder at DelNovaSean BrynjelsenExecutive Officer, Director at Eton Pharmaceuticals

+ 7 more